News Medical on MSN2d
In silico docking of clinically approved drugs against the SARS-CoV-2 receptor-binding domain
Announcing a new article publication for BIO Integration journal. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in China in December 2019, rapidly spread worldwide, ...
pharmaphorum7h
Paving the road to functionally active antibody drugs
Antibody drugs have reshaped how we treat diseases. By harnessing the immune system to destroy tumours or temper excessive inflammation in autoimmune disorders, these therapeutics have become ...
New study reveals how Sudan virus binds to human cells
The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it ...
Lexaria begins biodistribution study for DehydraTECH GLP-1
Lexaria Bioscience (LEXX) announces that dosing has begun in its fluorescently tagged DehydraTECH-semaglutide rodent biodistribution study. The ...
Lexaria Biodistribution Study For DehydraTECH GLP-1 is Underway
KELOWNA, BC / ACCESSWIRE / February 6, 2025 / Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the 'Company' or 'Lexaria'), a global innovator in drug delivery platforms, announces that dosing ...
Light-activated drug shows promise for fighting psoriasis
Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal ...
News Medical on MSN1d
New insights into how the Sudan virus attaches to human cells
The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it infects cells. Currently, no approved treatments exist.
Science Daily2d
A light-activated drug to fight psoriasis
Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal patches and plaques). It affects about 2% of the population and is mediated ...
Science Daily1d
How Sudan virus binds to human cells
The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it infects cells. Currently, no approved treatments exist. To address this critical ...
Armed robbery in Revesby2d
UMN Study: Sudan Virus Binding to Human Cells Unveiled
The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it infects cells. Currently, no ...
Septerna: Great In Theory, Needs Proof
Septerna has a market cap of $750mn and $130mn in cash and ST investments. Discover SEPN's groundbreaking drug discovery ...
AlphaGalileo5d
Lopinavir and Ritonavir have High Affinity Toward the SARS-CoV-2 S-protein Receptor-binding Domain Sequenced in Brazil
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.